Pfizer Archives -

13th Annual Pharma Resource Planning and Portfolio Management

https://pharmaphorum.com/events/13th-annual-pharma-resource-planning-and-portfolio-management/

FDA approves latest Humira near-copy, as dozens of biosimilars head for market

https://pharmaphorum.com/news/fda-approves-latest-humira-near-copy-as-dozens-of-biosimilars-head-for-market/

Vyndaqel romps away in US, spurring earnings hike from Pfizer

https://pharmaphorum.com/news/vyndaqel-romps-away-in-us-spurring-earnings-hike-from-pfizer/

Which big pharma firms are best at digital?

https://pharmaphorum.com/views-analysis-digital/which-big-pharma-firms-are-best-at-digital/

Pfizer’s Xeljanz follow-up abrocitinib gathers momentum

https://pharmaphorum.com/news/pfizers-xeljanz-follow-up-abrocitinib-gathers-momentum/

ImaginAb joins with AZ, Pfizer and Takeda to develop tumour imaging tech

https://pharmaphorum.com/news/imaginab-joins-with-az-pfizer-and-takeda-to-develop-tumour-imaging-tech/

Pfizer inks deal with Ionis and Akcea for potential blockbuster diabetes and NASH drug

https://pharmaphorum.com/news/pfizer-inks-deal-with-ionis-and-akcea-for-potential-blockbuster-diabetes-and-nash-drug/

FDA approves J&J’s prostate cancer drug Erleada in new use, as Zytiga sales fall

https://pharmaphorum.com/news/fda-approves-jjs-prostate-cancer-drug-erleada-in-new-use-as-zytiga-sales-fall/

Keytruda combo cleared as first-line kidney cancer treatment in EU

https://pharmaphorum.com/news/keytruda-combo-cleared-first-line-kidney-cancer-treatment-eu/

Search